<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T4" position="float">
 <label>TABLE 4</label>
 <caption>
  <p>Clinical trials on effect of 
   <italic>Nigella sativa</italic> to various system disorders, diseases and conditions.
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <td align="center" rowspan="1" colspan="1">Intervention</td>
    <td align="center" rowspan="1" colspan="1">Application, duration</td>
    <td align="center" rowspan="1" colspan="1">Type of study</td>
    <td align="center" rowspan="1" colspan="1">Number of patients/study design
     <sup>a</sup>
    </td>
    <td align="center" rowspan="1" colspan="1">Control</td>
    <td align="center" rowspan="1" colspan="1">Main effects
     <sup>a</sup>
    </td>
    <td colspan="2" align="center" rowspan="1">References</td>
   </tr>
  </thead>
  <tbody valign="top">
   <tr>
    <td align="left" rowspan="1" colspan="1">Powdered 
     <italic>N. sativa</italic> seed
    </td>
    <td align="left" rowspan="1" colspan="1">Oral application for 8 weeks, 2 g of powder per day</td>
    <td align="left" rowspan="1" colspan="1">Double-blind placebo controlled randomized clinical trial</td>
    <td align="left" rowspan="1" colspan="1">40 patients with HT (aged between 22 and 50 years)</td>
    <td align="left" rowspan="1" colspan="1">Placebo (starch)</td>
    <td align="left" rowspan="1" colspan="1">↓ body weight and BMI, ↓ TSH and anti-TPO antibodies, ↑ T3, ↓ serum VEGF concentration</td>
    <td colspan="2" align="left" rowspan="1">(
     <xref rid="B76" ref-type="bibr">Farhangi et al., 2016</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>N. sativa</italic> powder
    </td>
    <td align="left" rowspan="1" colspan="1">Oral application for eight weeks</td>
    <td align="left" rowspan="1" colspan="1">Randomized double-blind trial</td>
    <td align="left" rowspan="1" colspan="1">40 patients with HT, 22–50 years</td>
    <td align="left" rowspan="1" colspan="1">Placebo (starch)</td>
    <td align="left" rowspan="1" colspan="1">↓ serum IL-23, ↓ TSH and anti-TPO antibodies, ↑ serum T3, ↓ body weight</td>
    <td colspan="2" align="left" rowspan="1">(
     <xref rid="B194" ref-type="bibr">Tajmiri et al., 2016</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>N. sativa</italic> seed powder
    </td>
    <td align="left" rowspan="1" colspan="1">Oral application for 8 weeks, 2 g per day</td>
    <td align="left" rowspan="1" colspan="1">Double-blind placebo controlled randomized clinical trial</td>
    <td align="left" rowspan="1" colspan="1">40 patients with HT (aged between 22 and 50 years)</td>
    <td align="left" rowspan="1" colspan="1">Placebo (starch)</td>
    <td align="left" rowspan="1" colspan="1">↓ serum LDL and T3, ↑ HDL</td>
    <td colspan="2" align="left" rowspan="1">(
     <xref rid="B77" ref-type="bibr">Farhangi et al., 2018</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>N. sativa</italic> powdered seed
    </td>
    <td align="left" rowspan="1" colspan="1">Oral application of 500 mg in combination with 500 mg of metformin, 10 mg atorvastatine, 150 mg aspirin</td>
    <td align="left" rowspan="1" colspan="1">Randomized clinical trial</td>
    <td align="left" rowspan="1" colspan="1">80 patients with metabolic syndrome and poor glycemic control (HbA1C&gt;7%)</td>
    <td align="left" rowspan="1" colspan="1">500 mg of metformin, 10 mg atorvastatine, 150 mg aspirin</td>
    <td align="left" rowspan="1" colspan="1">↓ FBG, PPBG, HbA1c, LDL</td>
    <td colspan="2" align="left" rowspan="1">(
     <xref rid="B156" ref-type="bibr">Najmi et al., 2012</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>N. sativa</italic> seed oil
    </td>
    <td align="left" rowspan="1" colspan="1">Oral application for 3 months, 2.5 mL two times daily</td>
    <td align="left" rowspan="1" colspan="1">Double-blind placebo controlled randomized clinical trial</td>
    <td align="left" rowspan="1" colspan="1">70 patients with type II diabetes</td>
    <td align="left" rowspan="1" colspan="1">Mineral oil</td>
    <td align="left" rowspan="1" colspan="1">↓ FBG, PPBG, HbA1c</td>
    <td colspan="2" align="left" rowspan="1">(
     <xref rid="B101" ref-type="bibr">Hosseini et al., 2013</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>N. sativa</italic> seed powder
    </td>
    <td align="left" rowspan="1" colspan="1">Oral application of 2g powder daily, for one year in addition to their standard medications</td>
    <td align="left" rowspan="1" colspan="1">Double-blind placebo controlled randomized clinical trial</td>
    <td align="left" rowspan="1" colspan="1">114 patients with type 2 diabetes on standard oral hypoglycemic drugs</td>
    <td align="left" rowspan="1" colspan="1">Placebo (charcoal)</td>
    <td align="left" rowspan="1" colspan="1">↓ FBG, HbA1c, TBARS ↑ TAC, SOD, GSH</td>
    <td colspan="2" align="left" rowspan="1">(
     <xref rid="B114" ref-type="bibr">Kaatabi et al., 2015</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>N. sativa</italic> oil soft gel capsules
    </td>
    <td align="left" rowspan="1" colspan="1">Oral application of 3g oil daily, for 12 weeks</td>
    <td align="left" rowspan="1" colspan="1">Double-blind placebo controlled randomized clinical trial</td>
    <td align="left" rowspan="1" colspan="1">72 patients with diabetes type 2</td>
    <td align="left" rowspan="1" colspan="1">Sunflower oil gel capsules</td>
    <td align="left" rowspan="1" colspan="1">↓ FBG, HbA1c, TG, LDL</td>
    <td colspan="2" align="left" rowspan="1">(
     <xref rid="B98" ref-type="bibr">Heshmati et al., 2015</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>N. sativa</italic> seed oil
    </td>
    <td align="left" rowspan="1" colspan="1">Oral application of 2.5 mL two times daily for two months</td>
    <td align="left" rowspan="1" colspan="1">Double-blind placebo controlled randomized clinical trial</td>
    <td align="left" rowspan="1" colspan="1">68 healthy men 20–45 years of age with infertility lasting more than one year</td>
    <td align="left" rowspan="1" colspan="1">Liquid paraffin</td>
    <td align="left" rowspan="1" colspan="1">Sperm count, motility, morphology and semen volume, pH and round cells were improved significantly</td>
    <td colspan="2" align="left" rowspan="1">(
     <xref rid="B126" ref-type="bibr">Kolahdooz et al., 2014</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>N. sativa</italic> seed extract
    </td>
    <td align="left" rowspan="1" colspan="1">Two test groups received 100 and 200 mg of extract twice a day for 8 weeks</td>
    <td align="left" rowspan="1" colspan="1">Double-blind placebo controlled randomized clinical trial</td>
    <td align="left" rowspan="1" colspan="1">119 healthy male volunteers, aged 35 to 50</td>
    <td align="left" rowspan="1" colspan="1">Placebo</td>
    <td align="left" rowspan="1" colspan="1">↓ systolic and diastolic BP in a dose-dependent manner</td>
    <td colspan="2" align="left" rowspan="1">(
     <xref rid="B58" ref-type="bibr">Dehkordi and Kamkhah, 2008</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>N. sativa</italic> seed oil
    </td>
    <td align="left" rowspan="1" colspan="1">Oral application of 2.5 mL oil two times per day for 8 weeks</td>
    <td align="left" rowspan="1" colspan="1">Randomized, double-blind placebo-controlled trial</td>
    <td align="left" rowspan="1" colspan="1">70 healthy volunteers aged 34–63 years</td>
    <td align="left" rowspan="1" colspan="1">Mineral oil</td>
    <td align="left" rowspan="1" colspan="1">↓ systolic and diastolic BPs</td>
    <td colspan="2" align="left" rowspan="1">(
     <xref rid="B73" ref-type="bibr">Fallah Huseini et al., 2013</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>N. sativa</italic> oil
    </td>
    <td align="left" rowspan="1" colspan="1">6 mg/kg daily, for 30 days</td>
    <td align="left" rowspan="1" colspan="1">Prospective and double-blind clinical study</td>
    <td align="left" rowspan="1" colspan="1">66 patients with allergic rhinitis</td>
    <td align="left" rowspan="1" colspan="1">Placebo</td>
    <td align="left" rowspan="1" colspan="1">↓ nasal mucosal congestion, nasal itching, sneezing attack, runny nose, turbinate hypertrophy, and mucosal pallor during the first 2 weeks of the study</td>
    <td colspan="2" align="left" rowspan="1">(
     <xref rid="B160" ref-type="bibr">Nikakhlagh et al., 2011</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>N. sativa</italic> nasal spray
    </td>
    <td align="left" rowspan="1" colspan="1">2 puffs/day of 
     <italic>N. sativa</italic> nasal spray (1 g/day of 
     <italic>N. sativa</italic>) for 8 weeks
    </td>
    <td align="left" rowspan="1" colspan="1">Randomized double-blind placebo-controlled trial</td>
    <td align="left" rowspan="1" colspan="1">65 patients with mild to moderate chronic rhinosinusitis</td>
    <td align="left" rowspan="1" colspan="1">Placebo (2 puffs/day of sodium chloride spray 0.65%)</td>
    <td align="left" rowspan="1" colspan="1">Lund–McKay, lund Kennedy, and Sino-nasal outcome Test-22 scores significantly decreased in the intervention group</td>
    <td colspan="2" align="left" rowspan="1">(
     <xref rid="B172" ref-type="bibr">Rezaeian and Amoushahi Khouzani, 2018</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>N. sativa</italic> oil
    </td>
    <td align="left" rowspan="1" colspan="1">Topical application, twice a day for 6 months</td>
    <td align="left" rowspan="1" colspan="1">Randomized, double-blind clinical trial</td>
    <td align="left" rowspan="1" colspan="1">52 patients with vitiligo lesions</td>
    <td align="left" rowspan="1" colspan="1">Fish oil</td>
    <td colspan="2" align="left" rowspan="1">Reduction in size of lesions</td>
    <td align="left" rowspan="1" colspan="1">(
     <xref rid="B84" ref-type="bibr">Ghorbanibirgani et al., 2014</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>N. sativa</italic> ointment (2%)
    </td>
    <td align="left" rowspan="1" colspan="1">Ointment (1 G) topically applied on eczematous lesions twice a day for a period of 4 weeks</td>
    <td align="left" rowspan="1" colspan="1">Randomized double-blind placebo-controlled trial</td>
    <td align="left" rowspan="1" colspan="1">60 patients with hand eczema, 18–60 years</td>
    <td align="left" rowspan="1" colspan="1">Betamethasone and eucerin</td>
    <td align="left" rowspan="1" colspan="1">↓ Dermatology life quality index score in 
     <italic>Nigella</italic> and betamethasone groups compared to eucerin
    </td>
    <td colspan="2" align="left" rowspan="1">(
     <xref rid="B219" ref-type="bibr">Yousefi et al., 2013</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>N. sativa</italic> seed powder and ointment
    </td>
    <td align="left" rowspan="1" colspan="1">12 weeks, group I: 10% w/w ointment with 
     <italic>N. sativa</italic> oil extract; group II: capsules with 500 mg of 
     <italic>N. sativa</italic> powder, three times daily; group III: Combination of ointment and capsules
    </td>
    <td align="left" rowspan="1" colspan="1">Randomized clinical trial</td>
    <td align="left" rowspan="1" colspan="1">60 patients with mild to moderate plaque and palmoplanter psoriasis</td>
    <td align="left" rowspan="1" colspan="1">-</td>
    <td align="left" rowspan="1" colspan="1">Group I—total healing of psoriatic lesions, with good response in 65% of patients, and a relapse rate of 31% four weeks after cessation of treatment; group II—good response in 50% of patients, with a relapse rate of 50% observed four weeks after application; group III—total cure of lesions, and good responses in 85% of patients, with a relapse rate of 18%</td>
    <td colspan="2" align="left" rowspan="1">(
     <xref rid="B111" ref-type="bibr">Jawad et al., 2014</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>N. sativa</italic> oil
    </td>
    <td align="left" rowspan="1" colspan="1">Two placebo capsules daily for 1 month, followed by a month of NS oil capsules 500 mg twice per day</td>
    <td align="left" rowspan="1" colspan="1">Placebo controlled clinical trial</td>
    <td align="left" rowspan="1" colspan="1">40 female atients with rheumatoid artritis</td>
    <td align="left" rowspan="1" colspan="1">Placebo (two starch capsules per day)</td>
    <td align="left" rowspan="1" colspan="1">↓ disease activity score, ↓ number of swollen joints and the duration of morning stiffness</td>
    <td colspan="2" align="left" rowspan="1">(
     <xref rid="B83" ref-type="bibr">Gheita and Kenawy, 2012</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>N. sativa</italic> oil
    </td>
    <td align="left" rowspan="1" colspan="1">500 mg oil capsules two times daily for 8 weeks</td>
    <td align="left" rowspan="1" colspan="1">Randomized, double-blind, placebo-controlled clinical trial</td>
    <td align="left" rowspan="1" colspan="1">42 patients with rheumatoid artritis</td>
    <td align="left" rowspan="1" colspan="1">Placebo</td>
    <td align="left" rowspan="1" colspan="1">↑ IL-10, ↓ MDA, ↓ NO</td>
    <td colspan="2" align="left" rowspan="1">(
     <xref rid="B87" ref-type="bibr">Hadi et al., 2016</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>N. sativa</italic> oil
    </td>
    <td align="left" rowspan="1" colspan="1">Topical application twice a day (in the morning and night) for 21 days</td>
    <td align="left" rowspan="1" colspan="1">Double-blind, parallel, clinical trial</td>
    <td align="left" rowspan="1" colspan="1">52 pateints with osteoarthritis, 60–80 years</td>
    <td align="left" rowspan="1" colspan="1">Diclofenac gel</td>
    <td align="left" rowspan="1" colspan="1">Better pain relief effect compared to diclofenac gel according to KOOS score (38.88 ± 17.84 and 50.33 ± 20.38, respectively)</td>
    <td colspan="2" align="left" rowspan="1">(
     <xref rid="B28" ref-type="bibr">Azizi et al., 2019</xref>)
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>N. sativa</italic> seed
    </td>
    <td align="left" rowspan="1" colspan="1">Oral administration: 500 mg in capsules (twice a day for 9 weeks)</td>
    <td align="left" rowspan="1" colspan="1">Randomized study</td>
    <td align="left" rowspan="1" colspan="1">20 healthy humans</td>
    <td align="left" rowspan="1" colspan="1">Placebo: Psyllium seed husk in capsuels</td>
    <td align="left" rowspan="1" colspan="1">Improvement in the parameters studied: Score of logical memory tests, attention test (letter cancenlation test and trail making test), cognitive test (Scroop)etc.</td>
    <td colspan="2" align="left" rowspan="1">(
     <xref rid="B39" ref-type="bibr">Bin Sayeed et al., 2013</xref>)
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>
    <sup>a</sup>BMI, body mass index; BP, blood pressure; FBG, fasting blood glucose; HbA1c, hemoglobin A1c; HT, Hashimoto’s thyroiditis; IL, interleukin; LDL, low density lipoprotein; MDA, malondialdehyde; PPBG, postprandial blood glucose; T3, total triiodothyronine; TAC, total antioxidant capacity; TBARS, thiobarbituric acid reactive substances; TG, triglycerides; TPO, thyroid peroxidase; TSH, thyroid-stimulating hormone; VEGF, vascular endothelial growth factor.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
